Australia's most trusted
source of pharma news
Friday, 1 May 2026
Friday, 1 May 2026
Subscribe
Login
Drought strikes May PBS listings
PBS listings have almost ground to a halt with only three additions to the scheme this month, compared to 17 in April and 12 in March.
New Top 25 Big Pharma is born
ICYMI: The buyout of Organon by Sun Pharma will create a new top-ranking pharma plus the other most popular stories this week
TODAY Your Week in 5 Minutes
Aussie pharma on the nose
Industry's approval rating among patients fell nine per cent, one of the worst global results but not everyone's in the bad books
TODAY
High-flyers on the move in pharma
Top-level appointments announced including one executive who has switched between the same two companies over eight years
30 April
TGA eyes five new drug filings
Regulatory pathways handed out by the TGA signals five new drugs are on the cusp of being filed in the coming months, if not sooner
30 April
Which CAR T saved Sam Neill?
An experimental therapy has eliminated Neill's cancer, with the actor describing himself as 'patient zero' for the new treatment
30 April
New GM calls out PBS wait times
Miniscule decline in wait time between TGA approval and PBS listing is nowhere near good enough, new Country Leader warns
29 April
Latest Jobs
Customer Service Team LeaderRegulatory Submissions SpecialistTerritory ManagerTrade Marketing ManagerProduct ManagerInternal Communications SpecialistStorepersonSenior Medical Manager26 more...
Pharma in Focus Jobs
Marketing & Communications (8)
- Trade Marketing Manager - Sydney
- Product Manager - New South Wales
- Internal Communications Specialist - Melbourne
- Trade Marketing Manager - Sydney
- Senior Product Manager - Sydney
- Associate Marketing Manager - OTC - Sydney
- Senior Data & Insights Analyst - Melbourne
- Data & Insights Analyst - Melbourne
Sales & Customer Relations (10)
- Customer Service Team Leader - Frenchs Forest
- Territory Manager - Melbourne
- Territory Manager - Surgical - Sydney
- Pharmaceutical Sales Representative - Sydney
- Account Manager - Sydney
- Senior Territory Manager - Melbourne
- Customer Service Lead - Frenchs Forest
- Customer Service Representative - St Leonards
- Customer Service Specialist - Frenchs Forest
- Customer Service Representative - East Ryde
Clinical & Medical, R&D (8)
- Senior Medical Manager - Melbourne
- Senior Medical Science Liaison - Melbourne
- Clinical Trial Start Up Specialist - Melbourne
- Clinical Project Manager - Oncology - Sydney, NSW
- Clinical Trials Investigator - Melbourne
- Senior Manager, Clinical Operations (Japan) - Tokyo, Japan
- Medical Lead - Sydney
- Pharmacovigilance and Medical Information Associate - Sydney
Regulatory, Pharmacovigilance & QA (4)
- Regulatory Submissions Specialist - Melbourne
- QA Specialist - Melbourne
- Senior Regulatory Affairs Associate - Sydney
- Pharmacovigilance and Medical Information Associate - Sydney
Executive Roles (1)
Other (6)
First May PBS listing goes to...
Cancer drug reimbursement win underlines the company's "ongoing investment in oncology" GM says, providing patients more choice
TODAY
Rising cost of PBAC submissions
Department releases its proposed fee structure for the processes of listing on the PBS, and just how much it expects to raise
TODAY
10-drug ANZ deal sealed
Exclusive commercial and licensing agreement could pave the way for 10 injectable, oral, and speciality drugs to be launched in ANZ
30 April
Next up: Ozempic pills for kids
Novo chases another first, aiming to file for a label expansion in the US and EU for oral semaglutide to treat T2 diabetes in kids and teens
30 April
Pharma off target, doctors say
Industry's concerted efforts to meaningfully engage with Australian doctors seems to be missing the mark
29 April
Largest packaging plant opens
This 36,000 sqm greenfield facility provides a central hub for efficient distribution and supply chain management for pharmas
29 April
CSL falls to nine-year low
Another attack on vaccines by the US Administration hit the Aussie giant 'at the worst possible time' sending its share price tumbling
29 April
Lilly eyes next goldmine
After hitting the jackpot with its treatments for weight loss and diabetes, this company looks to crack another monster market
29 April
PBAC greenlights new drugs
Out of 26 new PBS listing submissions considered by the PBAC in March, a massive 23 were recommended
28 April
Big Pharma goes under the hammer
A new Top 25 pharma will be created under this AU$16B buyout deal with a global footprint extending to 150 countries
28 April
Vax slide a drag on productivity
Pfizer uses pre-budget submission to call on the federal government to increase investment in preventative health
28 April
PBAC pushes biologics to first line
Nine recommendations for new indications plus a 'yes' to paediatric patients with Crohn's to going straight to biologics
28 April
New ALS treatment approved
Bumper list of medicines join the ARTG, including the first copycat of a PBS listed drug plus multiple brands containing semaglutide
28 April Approvals Action
Lilly refuses PBS listing price
After finally winning a PBAC recommendation on its fourth attempt, Lilly will not make this blockbuster available on the PBS
24 April